Shein's IPO plans in London are challenged by Stop Uyghur Genocide, alleging forced labour in its supply chain. The Financial Conduct Authority (FCA) faces pressure regarding the IPO approval. Shein ...
Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...
Baxter International Inc. , a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the ...